NOVEMBERASIA BUSINESS OUTLOOK19Having delved into markets like Kazakhstan, Uzbekistan, Ukraine, and more, he emphasizes the importance of understanding the nuances between government-driven healthcare systems and trade-based markets. This experience guides his decision-making process, opting to enter trade segments that contribute significantly to market share without navigating stringent government regulations. His leadership approach involves not just market understanding but also a deep comprehension of team dynamics across diverse cultures and perspectives. This wide-ranging experience has culminated in successfully establishing companies in multiple CIS countries within a year, leveraging a rich understanding of government policies, team dynamics, and market mentalities. As a Business Head and Founder, this breadth of experience proves invaluable, offering him a distinct advantage over others in comprehending multiple markets and adeptly managing various business facets, from sales and finance to logistics and corporate affairs."Embarking on a journey as an entrepreneur is like diving into the unknown, especially when venturing into unfamiliar territories. I've learned that starting from scratch is possible--I began with nothing but a vision. It's crucial to promise yourself to never give up on an idea that resonates within. Honesty and integrity must remain the cornerstones. Dream big, persevere, and believe in the dividends of persistence. Moreover, I urge fellow entrepreneurs to embrace these tough journeys for they often lead to faster progress and richer experiences", he highlights.The Silver LiningSatish shares, "In a span of just 10 years, our company emerged as a formidable force in a market dominated by established players. Overcoming language barriers and unfamiliar systems, we swiftly positioned ourselves as a leading entity in marketing and distribution. Recognizing the importance of localization, triggered a strategic shift. Inspired by the need to align with the local government, we embarked on establishing our manufacturing facility in Uzbekistan, a project realized amidst the challenges of the pandemic. By 2022, our production commenced, granting us an advantage. Having secured the top position with nearly $50 million in sales, the next phase involves leveraging our localization efforts to tap into a substantial share of the government budget, aiming to boost revenues by an additional $20 million within the next couple of years. Focusing on injectables, we strategically positioned our plant to cater to the evolving needs of a market primarily (60 percent) dominated by oral and injectable formulations."The company in record time of less than a year got GMP, GDP and GLP certified for its manufacturing facility and distribution warehouse which shows dedication of organization to excel to global market. Under Save Soil Campaign Serene Team planted over 2000 trees in Uzbekistan, the company strives to create an environment where sustainability is embraced and every individual. Serene Pharma's milestones, from certifications to pioneering initiatives like the QR code system, spotlights its innovation.
< Page 9 | Page 11 >